StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
107
This month
2
This year
12
Publishing Date
2024 - 03 - 28
2
2024 - 02 - 12
2
2023 - 03 - 20
2
2022 - 10 - 07
2
2022 - 09 - 13
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 15
1
2022 - 06 - 09
1
2022 - 06 - 03
2
2022 - 05 - 24
1
2022 - 05 - 16
1
2022 - 04 - 29
1
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 04 - 13
1
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 02 - 28
1
2022 - 02 - 23
1
2022 - 02 - 11
1
2022 - 02 - 10
1
2022 - 01 - 14
2
2022 - 01 - 10
1
2022 - 01 - 06
1
2021 - 11 - 29
2
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 10 - 22
1
2021 - 10 - 21
1
2021 - 10 - 07
2
2021 - 09 - 24
1
2021 - 09 - 15
1
2021 - 09 - 01
1
2021 - 08 - 16
1
2021 - 08 - 12
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 06 - 29
1
2021 - 06 - 24
1
2021 - 06 - 23
1
2021 - 06 - 16
1
2021 - 06 - 04
2
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 19
1
2021 - 04 - 15
1
2021 - 04 - 10
1
2021 - 03 - 19
1
2021 - 03 - 12
1
2021 - 03 - 10
1
2021 - 03 - 04
1
Sector
Communications
6
Finance
2
Health technology
107
Manufacturing
4
N/a
3
Process industries
2
Professional, scientific, and technical services
6
Technology services
1
Tags
Acquisition
2
Agreement
2
Antibody
3
Antiviral
2
Biotech
4
Biotech-bay
3
Biotechnology
3
Cancer
10
Clinical trials
2
Collaboration
2
Conference
8
Covid-19
2
Disease
4
Drug
6
Earnings
3
Events
2
Expansion
2
Financial
5
Financial results
6
Funding
2
Gene therapies
2
Gene therapy
2
Genetown
7
Global
11
Growth
2
Health
2
Hepatitis
2
Hiv
2
Hypertension
3
Immunotherapy
3
Impact
2
Iot
4
License
4
Liver
2
Lyn-005
2
Market
19
Million
3
Money
2
N/a
63
Nx-0479
2
Offering
2
People
9
Phase 1
2
Phase 2
4
Potential
4
Pre-clinical
5
Preclinical
6
Protein
2
Report
9
Research
11
Results
15
Sciences
5
Spac
3
Space
3
T-cell
5
Technology
4
Therapeutics
42
Therapy
10
Trial
9
Year
3
Entities
Abbott laboratories
7
Abbvie inc.
8
Abeona therapeutics inc.
2
Adaptimmune therapeutics plc
3
Advaxis, inc.
2
Alnylam pharmaceuticals, inc.
3
Amgen inc.
8
Applied genetic technologies corporation
2
Astellas pharma inc
2
Astrazeneca plc
4
Autolus therapeutics plc
2
Bellicum pharmaceuticals, inc.
2
Bluebird bio, inc.
4
Boston scientific corporation
2
Bristol-myers squibb company
12
Calliditas therapeutics ab
3
Celyad oncology sa
2
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
7
Exelixis, inc.
3
Fate therapeutics, inc.
2
G1 therapeutics, inc.
2
Gilead sciences, inc.
107
Glaukos corporation
2
Glaxosmithkline plc
10
Global blood therapeutics, inc.
2
Hookipa pharma inc.
3
Intellia therapeutics, inc.
3
Johnson & johnson
13
Jounce therapeutics, inc.
25
Karyopharm therapeutics inc.
2
Morphosys ag
2
Nektar therapeutics
2
Novartis ag
12
Novo nordisk a/s
2
Nurix therapeutics, inc.
4
Oncolytics biotech inc.
2
Orange
6
Orchard therapeutics plc
2
Pfizer, inc.
7
Poseida therapeutics, inc.
2
Precigen, inc.
3
Protara therapeutics, inc.
3
Regeneron pharmaceuticals, inc.
3
Regenxbio inc.
2
Sangamo therapeutics, inc.
4
Sanofi
16
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
6
Teva pharmaceutical industries ltd
2
Thermo fisher scientific inc
2
Uniqure n.v.
2
United therapeutics corporation
3
Viatris inc.
3
Voyager therapeutics, inc.
2
Xilio therapeutics inc
4
Symbols
ABBV
156
ABEO
115
ADCT
145
AKBA
116
ALDX
123
ALLO
177
AMGN
137
AMRN
133
AQST
147
ATHE
106
AXSM
116
AZN
116
BCLI
131
BMY
131
BTAI
167
CALT
141
FATE
255
FULC
134
GILD
107
GOOG
192
GOOGL
192
GSK
149
GTHX
136
HOTH
109
HZNP
146
JNJ
520
KPTI
166
LCTX
109
LLY
282
MCRB
116
MDNA
108
MOR
185
MPSYF
181
MS
207
NKTR
365
NRIX
147
NTLA
112
NVS
225
NVSEF
191
OCX
177
ONTX
113
OTLK
146
PSTV
123
PSTX
110
PTCT
265
RLFTF
109
RLFTY
109
SNY
704
SNYNF
546
SPRO
121
SRNE
229
SRPT
164
TGTX
148
TVTX
120
TXMD
189
UTHR
142
VTGN
116
VXRT
180
VYNE
172
YMAB
178
Exchanges
Nasdaq
107
Nyse
39
Crawled Date
2024 - 03 - 28
2
2024 - 02 - 12
2
2023 - 03 - 20
2
2022 - 10 - 07
2
2022 - 09 - 13
1
2022 - 08 - 30
1
2022 - 08 - 12
1
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 15
1
2022 - 06 - 09
1
2022 - 06 - 03
2
2022 - 05 - 24
1
2022 - 05 - 16
1
2022 - 04 - 29
1
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 04 - 13
1
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 02 - 28
1
2022 - 02 - 23
1
2022 - 02 - 11
1
2022 - 02 - 10
1
2022 - 01 - 14
2
2022 - 01 - 10
1
2022 - 01 - 06
1
2021 - 11 - 29
2
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 10 - 22
1
2021 - 10 - 21
1
2021 - 10 - 07
2
2021 - 09 - 24
1
2021 - 09 - 15
1
2021 - 09 - 01
1
2021 - 08 - 16
1
2021 - 08 - 12
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 06 - 29
1
2021 - 06 - 24
1
2021 - 06 - 23
1
2021 - 06 - 16
1
2021 - 06 - 04
2
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 27
1
2021 - 04 - 19
1
2021 - 04 - 15
1
2021 - 04 - 10
1
2021 - 03 - 19
1
2021 - 03 - 12
1
2021 - 03 - 10
1
2021 - 03 - 04
1
Crawled Time
01:00
1
02:00
1
04:00
2
04:20
1
08:00
1
11:00
5
12:00
9
12:06
1
12:15
6
12:20
1
13:00
9
13:15
1
13:20
7
13:30
1
14:00
8
14:15
2
14:20
3
14:30
5
15:00
7
15:30
2
16:00
1
16:20
1
17:00
6
18:00
3
19:00
2
19:47
1
20:00
8
21:00
2
22:00
6
23:00
4
Source
ir.voyagertherapeutics.com
1
www.biospace.com
44
www.fda.gov
1
www.globenewswire.com
30
www.nurixtx.com
1
www.prnewswire.com
30
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
symbols :
Gild
save search
Leap Therapeutics Announces $40 Million Private Placement
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
LPTX
|
$2.96
-1.33%
-1.35%
100K
|
Health Technology
|
-2.63%
|
O:
15.13%
H:
25.43%
C:
-11.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-1.79%
|
O:
0.5%
H:
0.83%
C:
0.28%
million
leap
therapeutics
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-04-01
(Crawled : 20:00)
- globenewswire.com
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-8.21%
|
O:
-0.08%
H:
0.04%
C:
-1.0%
business
year
pipeline
therapeutics
financial
results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.33
-0.7%
-0.74%
220K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.33%
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.28
4.06%
0.0%
130K
|
Professional, Scientific, and T...
|
100.31%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-8.37%
|
O:
0.33%
H:
0.85%
C:
0.0%
million
therapeutics
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.28
4.06%
0.0%
130K
|
Professional, Scientific, and T...
|
100.31%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-8.37%
|
O:
0.33%
H:
0.85%
C:
0.0%
il-12
license
program
agreement
Gilead Sciences Announces Completion of Acquisition of CymaBay
Published:
2024-03-22
(Crawled : 22:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-8.47%
|
O:
0.03%
H:
0.16%
C:
-0.68%
acquisition
sciences
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Published:
2024-02-28
(Crawled : 22:00)
- globenewswire.com
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-7.98%
|
O:
0.03%
H:
0.26%
C:
-0.85%
CBAY
|
$32.48
0.03%
8.4M
|
Health Technology
|
0.62%
|
O:
0.02%
H:
0.0%
C:
0.0%
year
update
financial
results
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
-2.91%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
-4.57%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.39
-1.56%
-1.58%
4.3M
|
Health Technology
|
-1.49%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-10.14%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
News
|
$145.16
-0.11%
-0.19%
400K
|
Health Technology
|
-14.28%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
Published:
2024-02-12
(Crawled : 14:30)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-9.19%
|
O:
-0.35%
H:
2.36%
C:
1.42%
CBAY
|
$32.48
0.03%
8.4M
|
Health Technology
|
30.09%
|
O:
27.92%
H:
0.97%
C:
0.88%
liver
acquisition
sciences
therapeutics
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-10.12%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-13.0%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$116.55
-1.14%
-1.12%
500K
|
Health Technology
|
-1.77%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-16.61%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
$262.75
-0.5%
-0.49%
1.4M
|
Health Technology
|
-14.61%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-10.59%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
$92.57
-0.55%
0.27%
840K
|
Health Technology
|
-13.6%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.024
-14.29%
-8.85%
57K
|
Health Technology
|
-33.33%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-15.83%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.8
-0.83%
-0.83%
1.2M
|
Health Technology
|
-11.96%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Lyndra Therapeutics Announces Positive Data from Pivotal Phase 3 Study with Oral Weekly Risperidone (LYN-005) for Schizophrenia
Published:
2024-01-04
(Crawled : 20:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-19.86%
|
O:
0.37%
H:
1.38%
C:
0.82%
lyn-005
positive
schizophrenia
therapeutics
study
Lyndra Therapeutics Raises $101 Million in Series E Funding
Published:
2023-12-21
(Crawled : 15:00)
- biospace.com/
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-14.87%
|
O:
0.29%
H:
0.76%
C:
0.14%
million
series
therapeutics
funding
Pulmonary Arterial Hypertension Market Size Valuation Will Exceed USD 11.35 Billion By 2032, at 5.0% CAGR: Polaris Market Research
Published:
2023-11-29
(Crawled : 15:30)
- prnewswire.com
VTRS
|
$11.12
0.18%
0.09%
2.3M
|
Health Technology
|
21.66%
|
O:
0.11%
H:
0.44%
C:
-0.22%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-4.27%
|
O:
-0.04%
H:
0.0%
C:
0.0%
UTHR
|
$236.93
0.69%
0.78%
480K
|
Health Technology
|
2.14%
|
O:
0.35%
H:
1.23%
C:
0.38%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-10.21%
|
O:
0.46%
H:
0.8%
C:
0.51%
research
hypertension
market
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
$9.47
0.11%
-1.11%
520K
|
Manufacturing
|
-23.18%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.67
-2.03%
-1.96%
730K
|
Health Technology
|
26.07%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
News
|
$13.16
0.08%
0.53%
1.2M
|
Health Technology
|
-3.66%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.76
-4.03%
-0.84%
280K
|
Health Technology
|
609.28%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
15.93%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
M
|
$3.77
-0.79%
-1.06%
770K
|
Health Technology
|
47.29%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-16.57%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$22.49
-1.66%
-1.78%
2.1M
|
Health Technology
|
9.54%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
Roy Baynes, MB.Bch., M.Med., Ph.D.
Published:
2023-10-25
(Crawled : 17:00)
- nurixtx.com
NRIX
2 d
|
$14.44
2.56%
2.43%
1.5M
|
Health Technology
|
210.54%
|
O:
-1.08%
H:
0.0%
C:
-7.61%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-14.4%
|
O:
-0.31%
H:
0.89%
C:
0.62%
HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
Published:
2023-10-18
(Crawled : 11:00)
- globenewswire.com
HOOK
|
$0.7649
0.32%
0.91%
170K
|
Health Technology
|
45.32%
|
O:
3.19%
H:
0.98%
C:
-1.98%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-16.87%
|
O:
-0.01%
H:
0.3%
C:
-0.99%
hepatitis
pharma
vaccine
publication
sciences
preclinical
collaboration
virus
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
Published:
2023-09-13
(Crawled : 14:30)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-51.54%
|
O:
-2.2%
H:
0.9%
C:
-1.8%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-12.89%
|
O:
0.26%
H:
0.69%
C:
0.4%
FULC
|
$7.06
-1.26%
-1.27%
530K
|
Health Technology
|
36.97%
|
O:
-0.19%
H:
0.0%
C:
-8.83%
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-55.91%
|
O:
-1.12%
H:
3.87%
C:
-1.94%
RNA
|
$23.04
-2.17%
-2.21%
930K
|
Health Technology
|
226.63%
|
O:
1.25%
H:
3.01%
C:
-2.6%
fda
biotech
momentum
Oral Antiviral Market Report 2023: Demand for Novel Therapeutics Boosts Opportunities
Published:
2023-09-09
(Crawled : 04:20)
- prnewswire.com
VTRS
|
$11.12
0.18%
0.09%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.27
-0.83%
0.26%
1.9M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
0.33%
8.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.14%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
0.65%
-14.18%
40
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
Email alert
Add to watchlist
report
antiviral
therapeutics
market
Everest Medicines Announces Interim Results for First Half of 2023
Published:
2023-08-24
(Crawled : 01:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
0.24%
31M
|
Health Technology
|
-30.66%
|
O:
-0.5%
H:
0.45%
C:
-0.86%
GILD
|
News
|
$66.16
-1.15%
-1.16%
4.9M
|
Health Technology
|
-13.16%
|
O:
0.27%
H:
1.15%
C:
-1.19%
CALT
|
News
|
$17.65
-5.82%
-2.4%
6K
|
Health Technology
|
-0.84%
|
O:
-4.72%
H:
0.0%
C:
0.0%
results
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
60%
40%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.